GO FUND IT NOW

National Institutes of Health

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing January 7, 2028.

Funder
National Institutes of Health
Funding
Grant / contract
Deadline
Jan 7, 2028
(525d left)
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) | Go Fund It Now